Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksORPH.L Share News (ORPH)

  • There is currently no data for ORPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Cyanconnode, Rosslyn Data rise on contract wins

Mon, 22nd Aug 2022 11:03

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

----------

AIM - WINNERS

----------

Cyanconnode Holdings PLC, up 29% at 19.00 pence, 12-month range 11.00p-29.85p. The narrowband radio frequency smart mesh networks firm says Indian subsidiary has received its largest-ever order. CyanConnode India Pvt Ltd has received an order from Genus Power Infrastructures Ltd for one million Omnimesh modules, together with advanced metering infrastructure, standards-based hardware, Omnimesh head-end software, perpetual license and a support and maintenance contract. The support and maintenance contract runs for eight years, starting upon completion of the installation phase.

----------

Rosslyn Data Technologies PLC, up 12% at 2.36p, 12-month range 1.50p-5.98p. The data management and analytics service provider wins first enterprise customer through partnership with indirect procurement service provider Chain IQ Group AG. Says initial contract is "of relatively small monetary value" but expects further contracts to come from partnership. Chief Executive Paul Watts says deal highlights value of partnership with Chain IQ.

----------

Open Orphan PLC, up 5.9% at 11.91p, 12-month range 10.00p-27.75p. The pharmaceutical services firm says subsidiary hVIVO Ltd has won a GBP10.4 million contract. Open Orphan says the contract has been signed with an "existing top five global pharmaceutical client". This is the third human challenge contract signed with the client, it adds.

----------

AIM - LOSERS

----------

Artemis Resources Ltd, down 11% at 2.05p, 12-month range 1.44p-5.00p. The miner says no significant nickel or copper results are found in laboratory analyses of samples from the first drill hole at the Osborne nickel prospect. Further, in a separate statement regarding its Greater Carlow project, holes ARC395 and ARC396 "did not return any significant mineralisation, in line with the offset of the lodes already discovered by holes ARC403 and ARC404," the Perth-based miner with gold, copper and cobalt projects in Australia adds.

----------

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
11 May 2020 12:03

UK TRADING UPDATE SUMMARY: Blencowe And BlueRock Recommence Operations

UK TRADING UPDATE SUMMARY: Blencowe And BlueRock Recommence Operations

Read more
11 May 2020 09:06

Open Orphan inks contract with Quotient on Covid-19 antibody testing

(Sharecast News) - Pharmaceutical services company Open Orphan's hVIVO subsidiary has entered into an exclusive contract with Quotient to support Covid-19 antibody testing in the UK.

Read more
4 May 2020 16:21

Open Orphan signs ?3.5m deal with US biotech firm

(Sharecast News) - Pharmaceutical services company Open Orphan announced the signing of a new contract with an unnamed US biotechnology company on Monday, for the provision of a respiratory syncytial virus (RSV) human challenge study.

Read more
4 May 2020 14:35

Open Orphan CEO Steps Down; Inks New Challenge Study Contract

Open Orphan CEO Steps Down; Inks New Challenge Study Contract

Read more
23 Apr 2020 15:40

UK TRADING UPDATE SUMMARY: Braemar Says Oil Tankers Wanted For Storage

UK TRADING UPDATE SUMMARY: Braemar Says Oil Tankers Wanted For Storage

Read more
23 Apr 2020 10:21

Open Orphan begins testing of Covid-19 anti-viral treatment

(Sharecast News) - Pharmaceutical services company Open Orphan said it had started testing an anti-viral drug to treat Covid-19 on behalf of its client Nearmedic International.

Read more
10 Mar 2020 14:48

Open Orphan Notes Publication Of FLU-v Vaccine Study In Journal

Open Orphan Notes Publication Of FLU-v Vaccine Study In Journal

Read more
9 Mar 2020 14:17

Open Orphan Starts On Coronavirus Challenge Study Model

Open Orphan Starts On Coronavirus Challenge Study Model

Read more
6 Mar 2020 15:23

Open Orphan agrees study with European biotech firm

(Sharecast News) - Orphan drugs-focussed pharmaceutical company Open Orphan announced the signing of a new contract with an unnamed European biotechnology firm for the provision of an RSV human challenge study.

Read more
6 Mar 2020 11:57

Open Orphan Inks New Virus Study Contract With Potential Follow-On

Open Orphan Inks New Virus Study Contract With Potential Follow-On

Read more
27 Feb 2020 17:56

EXECUTIVE CHANGE SUMMARY: Burford Capital Adds Independent Directors

EXECUTIVE CHANGE SUMMARY: Burford Capital Adds Independent Directors

Read more
13 Feb 2020 14:45

Open Orphan Appoints Interim CFO Leo Toole To Permanent Role

Open Orphan Appoints Interim CFO Leo Toole To Permanent Role

Read more
31 Jan 2020 15:39

Open Orphan raising at least ?5m for merger with hVIVO

(Sharecast News) - Pharmaceutical services company Open Orphan announced a fundraising to raise a minimum of £5m before expenses via a conditional placing of new ordinary shares on Friday, at a price of 6.1p each, to institutional and other investors.

Read more
31 Jan 2020 12:39

Open Orphan Raises GBP5.3 Million To Fund hVIVO Synergy Programme

Open Orphan Raises GBP5.3 Million To Fund hVIVO Synergy Programme

Read more
23 Jan 2020 18:32

Open Orphan In Talks With Investors Regarding GBP5 Million Placing

Open Orphan In Talks With Investors Regarding GBP5 Million Placing

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.